Prevalence and healthcare costs of obesity-related comorbidities: evidence from an electronic medical records system in the United States
- PMID: 26134917
- DOI: 10.3111/13696998.2015.1067623
Prevalence and healthcare costs of obesity-related comorbidities: evidence from an electronic medical records system in the United States
Abstract
Objective: This study estimated the economic burden of obesity-related comorbidities (ORCs) in the US, at both the person and population levels.
Methods: The Geisinger Health System provided electronic medical records and claims between January 2004 and May 2013 for a sample of 153,561 adults (50% males and 97% white). Adults with < 2 years of data, who were underweight (body mass index (BMI) < 18.5 kg/m(2)), or had diseases causing major weight change (e.g., malignancy) during the study period (i.e., continuous enrollment in health plans) were excluded. A total of 21 chronic conditions, with established association with obesity in the literature, were identified by diagnosis codes and/or lab test results. The total healthcare costs were measured in each year. The association between annual costs and ORCs was assessed by a regression, which jointly considered all the ORCs. The per-person incremental costs of a single comorbidity, without any of the other ORCs, were calculated. The population-level economic burden was the product of each ORC's incremental costs and the annual prevalence of the ORC among 100,000 individuals. The prevalence of ORCs was stratified by obesity status to estimate the economic burden among 100,000 individuals with obesity and among those without.
Results: This study identified 56,895 adults (mean age = 47 years; mean BMI = 29.6 kg/m(2)). The annual prevalence of ORCs ranged from 0.5% for pulmonary embolism (PE) to 41.8% for dyslipidemia. The per-person annual incremental costs of a single ORC ranged from $120 for angina to $1665 for PE. Hypertensive diseases (HTND), dyslipidemia, and osteoarthritis were the three most expensive ORCs at the population level; each responsible for ≥$18 million annually among 100,000 individuals. HTND and osteoarthritis were much more costly among individuals with obesity than those without obesity.
Limitations: Data were from a small geographic region.
Conclusions: ORCs are associated with substantial economic burden, especially for those requiring continuous treatments.
Keywords: Obesity – Obesity-related comorbidities – Economic burden – Prevalence.
Similar articles
-
Real-world costs of obesity-related complications over eight years: a US retrospective cohort study in 28,500 individuals.Int J Obes (Lond). 2023 Dec;47(12):1239-1246. doi: 10.1038/s41366-023-01376-4. Epub 2023 Sep 18. Int J Obes (Lond). 2023. PMID: 37723273 Free PMC article.
-
Complication-specific direct medical costs by body mass index for 13 obesity-related complications: a retrospective database study.J Manag Care Spec Pharm. 2021 Feb;27(2):210-222. doi: 10.18553/jmcp.2020.20272. Epub 2020 Dec 14. J Manag Care Spec Pharm. 2021. PMID: 33307936 Free PMC article.
-
Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.Appl Health Econ Health Policy. 2013 Jun;11(3):299-304. doi: 10.1007/s40258-013-0027-z. Appl Health Econ Health Policy. 2013. PMID: 23580074
-
Scoping review report: obesity in older adults.Int J Obes (Lond). 2012 Sep;36(9):1141-50. doi: 10.1038/ijo.2012.29. Epub 2012 Mar 13. Int J Obes (Lond). 2012. PMID: 22410960 Review.
-
Obesity and overweight in Canada: an updated cost-of-illness study.Obes Rev. 2010 Jan;11(1):31-40. doi: 10.1111/j.1467-789X.2009.00579.x. Epub 2009 Apr 21. Obes Rev. 2010. PMID: 19413707 Review.
Cited by
-
The Impact of Metabolic and Bariatric Surgery on Apo B100 Levels in Individuals with high BMI: A Multi-Centric Prospective Cohort Study.Obes Surg. 2024 Jul;34(7):2454-2466. doi: 10.1007/s11695-024-07258-6. Epub 2024 May 15. Obes Surg. 2024. PMID: 38744799
-
Electro-acupuncture for central obesity: a patient-assessor blinded, randomized sham-controlled clinical trial.BMC Complement Med Ther. 2024 Jan 29;24(1):62. doi: 10.1186/s12906-024-04340-5. BMC Complement Med Ther. 2024. PMID: 38287303 Free PMC article. Clinical Trial.
-
A comparison between weight loss outcomes with anti-obesity medications before and during Covid-19 pandemic at a tertiary weight management center.Obes Pillars. 2022 Dec 1;4:100046. doi: 10.1016/j.obpill.2022.100046. eCollection 2022 Dec. Obes Pillars. 2022. PMID: 37990666 Free PMC article.
-
Real-world costs of obesity-related complications over eight years: a US retrospective cohort study in 28,500 individuals.Int J Obes (Lond). 2023 Dec;47(12):1239-1246. doi: 10.1038/s41366-023-01376-4. Epub 2023 Sep 18. Int J Obes (Lond). 2023. PMID: 37723273 Free PMC article.
-
Effectiveness of internet-based and mobile-based interventions for adults with overweight or obesity experiencing symptoms of depression: a systematic review protocol.BMJ Open. 2023 Jun 20;13(6):e067930. doi: 10.1136/bmjopen-2022-067930. BMJ Open. 2023. PMID: 37339836 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous